BAT’s US Bio-tech arm, Kentucky BioProcessing (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational New Drug application by the U.S. Food and Drug Administration (FDA). Enrollment for the study is expected to begin shortly. Full press release, intended for use by the media only, available at BAT.com.
Latest Articles
Reynolds American Submits Comment on FDA Draft Guidance for Flavored ENDS
In response to FDA’s open public comment period in March of 2026 regarding Draft Guidance on Applications for Flavored E-Cigarettes, Reynolds American submitted the following comment: Re: Docket No. FDA-2026-D-1817 (91 Fed. Reg. 11980, Mar. 11, 2026) – “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications—Considerations Related to Youth Risk” RAI Services Company … Continued
Reynolds American Expands Manufacturing Workforce at American Snuff Company in Clarksville
More than 50 new manufacturing roles at Clarksville facility underscores continued investment in future-ready U.S. manufacturing careers. Clarksville, Tenn., (March 26, 2026) – As part of the Reynolds American companies’ (Reynolds American) significant investment in American manufacturing, American Snuff Company, a Reynolds American company, is hiring more than 50 new manufacturing roles at its Clarksville, … Continued
Growing Tomorrow: Reynolds American Commits to Invest $3.2 Billion by 2030 to Grow U.S. Manufacturing and Innovation
Investment supports more than 2,000 U.S. jobs while expanding manufacturing capacity and fueling innovation across a multicategory portfolio WINSTON-SALEM, N.C., (March 5, 2026) — The Reynolds American companies (Reynolds American) announced a forward-looking commitment to invest more than $3.2 billion across its U.S. operations by 2030, reinforcing its long-term focus on value creation and … Continued
CEO David Waterfield Discusses Reynolds’ Next Chapter in Custom Content from WSJ
The Reynolds American organization (Reynolds) has partnered with Custom Content from WSJ to highlight how the organization is defining its next era following its 150th anniversary last year. The feature explores how Reynolds is navigating one of the most significant evolutions in its history, transitioning from a combustible-products business toward a predominantly smokeless trajectory … Continued